Ohtani M, Fukushima S, Ito N, Koiso K, Niijima T
Cancer Chemother Pharmacol. 1983;11 Suppl:S64-6. doi: 10.1007/BF00256721.
The effects of adriamycin (ADR) and mitomycin C (MMC) as inhibitors of the development of bladder tumors in rats were studied. Six-week-old female F344 rats were divided into nine groups, five of which received 0.05% N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) in their drinking water for the first 4 weeks, no treatment for 1 week, and then intravesical instillation once a week of ADR, MMC, or physiological saline or no instillation (no catheterization) for 12 weeks. The other four groups received no BBN for the first 5 weeks of the experiment and then received ADR, MMC, or physiological saline as above for 12 weeks. The bladders were examined by light microscopy 17 weeks after the beginning of the experiment. Results showed that development of preneoplastic lesions induced in the bladders of the rats by BBN was stimulated by subsequent instillation of ADR or MMC. This result suggests that ADR and MMC have promoting activities in bladder carcinogenesis of rats.
研究了阿霉素(ADR)和丝裂霉素C(MMC)作为大鼠膀胱肿瘤发生抑制剂的作用。六周龄雌性F344大鼠被分为九组,其中五组在最初4周饮用含0.05% N-丁基-N-(4-羟丁基)亚硝胺(BBN)的水,1周不进行处理,然后每周进行一次膀胱内灌注ADR、MMC或生理盐水,或不进行灌注(不插管),持续12周。另外四组在实验的前5周不给予BBN,然后像上述那样给予ADR、MMC或生理盐水,持续12周。在实验开始17周后,通过光学显微镜检查膀胱。结果显示,随后灌注ADR或MMC会刺激BBN诱导的大鼠膀胱癌前病变的发生。这一结果表明,ADR和MMC在大鼠膀胱癌发生过程中具有促进作用。